These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31952977)

  • 1. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT
    Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function.
    Kawamukai M; Hashimoto A; Koyama M; Nagano N; Nishida J; Mochizuki A; Kouzu H; Muranaka A; Kokubu N; Nagahara D; Yuda S; Tsuchihashi K; Miura T
    Heart Vessels; 2019 Nov; 34(11):1789-1800. PubMed ID: 31119378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
    Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
    Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma Pim-1 and its clinical significance in patients with pulmonary arterial hypertension.
    Zhu T; Luo J; Wang Y; Xiong X; Sheng B; Yang X; Ndongala NAMT; Li J
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):752-760. PubMed ID: 31066078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Pulmonary Capacitance at Rest and During Exercise in Idiopathic Pulmonary Arterial Hypertension.
    Jain P; Rao S; Macdonald P; Kotlyar E; Jabbour A; Hayward C; Keogh A
    Heart Lung Circ; 2019 Feb; 28(2):289-294. PubMed ID: 29150159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
    D'Alto M; Di Maio M; Argiento P; Romeo E; Rea G; Liccardo B; Del Giudice C; Vergara A; Caiazza E; Del Vecchio GE; Di Vilio A; Gargani L; D'Andrea A; Bossone E; Golino P; Picano E; Naeije R
    Eur J Heart Fail; 2024 Apr; 26(4):817-824. PubMed ID: 38404257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
    Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
    Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
    Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
    Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
    Chen Y; Li J; Li F; Chen Z; Chen Z; Luo J; Qiu H; Chen W; Hu J; Luo X; Tan Y; Rathinasabapathy A; Chen J; Li J
    Chest; 2024 May; 165(5):1211-1223. PubMed ID: 38040053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study.
    Zhang S; Yang T; Xu X; Wang M; Zhong L; Yang Y; Zhai Z; Xiao F; Wang C
    BMC Pulm Med; 2015 May; 15():50. PubMed ID: 25934483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Noninvasive Assessment of Pulmonary Arterial Stiffness Using Velocity Transfer Function.
    Gupta A; Sharifov OF; Lloyd SG; Tallaj JA; Aban I; Dell'italia LJ; Denney TS; Gupta H
    J Am Heart Assoc; 2018 Sep; 7(18):e009459. PubMed ID: 30371198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEDD9 targets
    Samokhin AO; Stephens T; Wertheim BM; Wang RS; Vargas SO; Yung LM; Cao M; Brown M; Arons E; Dieffenbach PB; Fewell JG; Matar M; Bowman FP; Haley KJ; Alba GA; Marino SM; Kumar R; Rosas IO; Waxman AB; Oldham WM; Khanna D; Graham BB; Seo S; Gladyshev VN; Yu PB; Fredenburgh LE; Loscalzo J; Leopold JA; Maron BA
    Sci Transl Med; 2018 Jun; 10(445):. PubMed ID: 29899023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right Ventricular Function is Associated With Quality of Life in Patients With Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension.
    Wang H; Wang Q; Tian Z; Guo X; Lai J; Li M; Zhao J; Liu Y; Zeng X; Fang Q
    Heart Lung Circ; 2019 Nov; 28(11):1655-1663. PubMed ID: 30301670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.
    Bredfelt A; Rådegran G; Hesselstrand R; Arheden H; Ostenfeld E
    ESC Heart Fail; 2018 Oct; 5(5):864-875. PubMed ID: 29916558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
    Khirfan G; Li M; Wang X; Dweik RA; Heresi GA; Tonelli AR
    J Heart Lung Transplant; 2021 Jul; 40(7):614-622. PubMed ID: 33962868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
    Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
    BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.